The interval since first symptoms until diagnosis of squamous cell carcinoma in the head and neck region is still a problem in southern Brazil.
Journal
Medicina oral, patologia oral y cirugia bucal
ISSN: 1698-6946
Titre abrégé: Med Oral Patol Oral Cir Bucal
Pays: Spain
ID NLM: 101231694
Informations de publication
Date de publication:
01 Nov 2020
01 Nov 2020
Historique:
received:
28
02
2020
accepted:
17
09
2020
pubmed:
11
10
2020
medline:
4
11
2020
entrez:
10
10
2020
Statut:
epublish
Résumé
The aim was to examine the interval since first symptoms until final diagnosis of squamous cell carcinoma (SCC) in the head and neck region in southern Brazil. The individuals were prospectively selected and underwent anamnesis, physical examination and interview in the first medical consultation at a Cancer Hospital from south of Brazil. From 488 patients who underwent clinical examination, 105 were included in the study with diagnosis of SCC. Patients average interval from first symptoms to final diagnosis was 152 days (median 86; max:1105; min: 1), the average professional interval was 108 days (median: 97; max:525; min: 1) , and the average total period interval was 258 days (median: 186; max:1177; min: 45). Factors statistically associated with patient and diagnosis itinerary intervals were smoking and poorly adapted dentures and distance from home to hospital, respectively. The identification of the itinerary characteristics of this specific population may reflect in more effective public policies, such as primary and secondary prevention programs, aiming to increase the survival of oncological patient. Furthermore, the knowledge of the variables that influence the late diagnosis minimizes patient's journey in search of care to cancer centers through health programs.
Sections du résumé
BACKGROUND
BACKGROUND
The aim was to examine the interval since first symptoms until final diagnosis of squamous cell carcinoma (SCC) in the head and neck region in southern Brazil.
MATERIAL AND METHODS
METHODS
The individuals were prospectively selected and underwent anamnesis, physical examination and interview in the first medical consultation at a Cancer Hospital from south of Brazil.
RESULTS
RESULTS
From 488 patients who underwent clinical examination, 105 were included in the study with diagnosis of SCC. Patients average interval from first symptoms to final diagnosis was 152 days (median 86; max:1105; min: 1), the average professional interval was 108 days (median: 97; max:525; min: 1) , and the average total period interval was 258 days (median: 186; max:1177; min: 45). Factors statistically associated with patient and diagnosis itinerary intervals were smoking and poorly adapted dentures and distance from home to hospital, respectively.
CONCLUSIONS
CONCLUSIONS
The identification of the itinerary characteristics of this specific population may reflect in more effective public policies, such as primary and secondary prevention programs, aiming to increase the survival of oncological patient. Furthermore, the knowledge of the variables that influence the late diagnosis minimizes patient's journey in search of care to cancer centers through health programs.
Identifiants
pubmed: 33037811
pii: 23781
doi: 10.4317/medoral.23781
pmc: PMC7648913
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e769-e774Références
Eur J Oral Sci. 2008 Apr;116(2):141-7
pubmed: 18353007
Community Dent Oral Epidemiol. 2006 Oct;34(5):337-43
pubmed: 16948672
Aust Dent J. 2016 Mar;61(1):29-34
pubmed: 25816690
Cancer Epidemiol. 2018 Apr;53:141-148
pubmed: 29438925
JAMA Otolaryngol Head Neck Surg. 2019 Feb 1;145(2):166-177
pubmed: 30383146
Clin Otolaryngol. 2018 Feb;43(1):164-171
pubmed: 28627802
Perm J. 2018 Mar 30;22:17-152
pubmed: 29616906
Br J Cancer. 2012 Mar 27;106(7):1262-7
pubmed: 22415239
Oral Dis. 2018 Apr;24(3):347-354
pubmed: 28862788
Int J Oral Sci. 2014 Mar;6(1):39-45
pubmed: 24287962
BMC Cancer. 2017 Oct 30;17(1):706
pubmed: 29084516
Otolaryngol Head Neck Surg. 2020 Apr;162(4):446-457
pubmed: 32093572
Eur J Cancer B Oral Oncol. 1994 May;30B(3):167-73
pubmed: 7920162
Br Dent J. 2000 Mar 11;188(5):262-5
pubmed: 10758688
Head Neck. 2016 Apr;38 Suppl 1:E2182-9
pubmed: 25783770
Community Dent Oral Epidemiol. 2018 Dec;46(6):592-600
pubmed: 30004138
Curr Oncol. 2018 Feb;25(1):67-72
pubmed: 29507486
Eur J Oral Sci. 2009 Oct;117(5):541-6
pubmed: 19758250
Qual Quant. 2009 May;43(3):333-349
pubmed: 20046840
Med Oral Patol Oral Cir Bucal. 2017 Jul 1;22(4):e478-e483
pubmed: 28578373
Oral Oncol. 2020 May;104:104626
pubmed: 32146387
Psychooncology. 2019 May;28(5):1041-1047
pubmed: 30828881
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Apr;117(4):424-9
pubmed: 24556495
Oral Dis. 2018 Mar;24(1-2):124-127
pubmed: 29480613
PLoS One. 2019 Oct 25;14(10):e0224067
pubmed: 31652279
Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2935-2941
pubmed: 30362327
Oral Oncol. 2018 Feb;77:137
pubmed: 29289443
Oral Dis. 2018 Mar;24(1-2):112-114
pubmed: 29480638